Φορτώνει......
Pathways to ensure universal and affordable access to hepatitis C treatment
Direct-acting antivirals (DAAs) have dramatically changed the landscape of hepatitis C treatment and prevention. The World Health Organization has called for the elimination of hepatitis C as a public health threat by 2030. However, the discrepancy in DAA prices across low-, middle- and high-income...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMC Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6176525/ https://ncbi.nlm.nih.gov/pubmed/30296935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-018-1162-z |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|